Discover how brand manufacturers produce authorized generics to retain market share after patent expiry. Learn about the production process, pricing strategies, and consumer impact of this pharmaceutical tactic.
Learn MoreThe Federal Circuit Court holds exclusive authority over all U.S. pharmaceutical patent cases, shaping how generics enter the market, how patents are challenged, and how dosing innovations are protected. Its rulings on ANDA jurisdiction, Orange Book listings, and obviousness standards have transformed drug development and litigation.
Learn More